bpc-157 recommended dosage human Dosing (Common Protocols), 🔹 Oral / Subcutaneous, • 500 mcg daily, • Duration: 6 weeks, 🔹 Intramuscular / Peritendinous, • 1 mg daily, • Duration: 6 weeks, ⚠️ Note:, Not approved by FDA or Five reasons adding peptides to

Because BPC 157 works systemically, the SubQ injection does not need to be close to the injury

148 MargittaiM.LangenR

AOD-9604 5 mg Key Specifications Peptide Name: AOD-9604 Peptide Type: Synthetic peptide fragment Derived From: C-terminal region of human growth hormone Quantity: 5mg per vial Form: Lyophilized (freeze-dried) powder Grade: Research grade Packaging: Sterile, sealed vial Common Research Applications AOD-9604 is utilized in non-clinical laboratory research related to: Metabolic pathway modeling Growth hormonerelated signaling research Peptide-receptor interaction studies Molecular stability and degradation analysis Experimental peptide behavior in controlled systems All research use must comply with institutional protocols and applicable regulations

BPC-157 is a synthetic pentadecapeptide (a peptide made up of 15 amino acids) based on a segment from a natural peptide (BPC) derived from human gastric juice.3 4 Insider Tip: Other names for BPC-157 are body protection compound 157, BPC-15, bepecin, PLD-116, PL-10, and PL-14736. Some also refer to BPC-157 as the Wolverine peptide due to its potential to support healing

Central nervous system action of TRH to stimulate gastric function and ulceration

Per CMS NCCI Policy Manual Chapter IV effective January 1, 2026, one unit of service applies to the joint and its surrounding bursae, regardless of how many aspirations or injections are performed